Skip to main content
Caplight Logo









Shanghai Epiprobe Biotechnology Co., Ltd.

Shanghai Epiprobe Biotechnology Co., Ltd.

Private
ShanghaiHealthcare & Life Scienceshttps://epiprobe.net/

Last Round

Series B

Apr 11, 2022

Total Funding Raised

$15.7M

Company Overview

Shanghai Epiprobe Biotechnology Co., Ltd. is a biotechnology company that develops molecular diagnostic products for cancer DNA methylation and precision theranostics.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Precision Medicine, Medical Devices

Business Model

B2B

Customer Profile

Services & Consulting, Usage-Based SaaS

AI Layer

Application

Keywords

liquid biopsyDNA methylationmolecular diagnosticscancer screeningearly cancer detectiondiagnostic test kitsprecision medicinebiotechoncology diagnosticsnon-invasive testingmedical laboratory serviceshealthcare SaaSmedical billing software

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Shanghai Epiprobe Biotechnology Co., Ltd. Comparables

Compare Shanghai Epiprobe Biotechnology Co., Ltd. with similar companies based on industry and business-model similarity.

Shanghai Epiprobe Biotechnology Co., Ltd. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Beijing OriginPoly Bio-Tec Co., Ltd.
86%
Creative Biosciences (Guangzhou) Co., Ltd.
82%
Wuhan KadWise Biotechnology Co., Ltd.
81%

Shanghai Epiprobe Biotechnology Co., Ltd. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BApr 11, 2022
Series ANov 1, 2020
Pre SeedAug 1, 2020

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 11, 2022

    $16M round with Dian Diagnostics Group and Tianjin Yiyi Hygiene Products Co Ltd.

  • Aug 1, 2020

    Completed a Pre Seed funding round.

Shanghai Epiprobe Biotechnology Co., Ltd. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Shanghai Epiprobe Biotechnology Co., Ltd. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Shanghai Epiprobe Biotechnology Co., Ltd.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersShanghai
Year Founded2018
Last FundingApr 11, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?